je.st
news
Tag: pharmaceuticals
BioCryst Pharmaceuticals Downgraded to Underperform at Bank of America
2015-11-16 05:33:57| Biotech - Topix.net
They presently have a $10.00 price target on the biotechnology company's stock, down from their previous price target of $12.00. Bank of America's price objective would indicate a potential upside of 3.95% from the stock's previous close.
Tags: america
bank
pharmaceuticals
downgraded
Alnylam Pharmaceuticals Keeping Multiple High-Potential Programs Moving Forward
2015-11-14 12:16:55| Biotech - Topix.net
Alnylam has had a summer of discontent as worries about the efficacy and tolerability of a lead drug combine with broader concerns about drug pricing and biotech valuations. Even if revusiran is inferior to Isis's rival compound, a backup compound could more than make up the difference and Alnylam is making broad overall progress with its pipeline.
Tags: multiple
forward
programs
moving
Wedbush Weighs in on Ironwood Pharmaceuticals' FY2018 Earnings
2015-11-08 08:39:41| Biotech - Topix.net
Analysts at Wedbush issued their FY2018 EPS estimates for shares of Ironwood Pharmaceuticals in a report released on Tuesday, Zacks Investment Research reports. Wedbush analyst D. Nierengarten expects that the firm will earn $1.01 per share for the year.
Tags: earnings
pharmaceuticals
weighs
ironwood
BioCryst Pharmaceuticals Expected to Post FY2019 Earnings of
2015-11-08 04:29:07| Biotech - Topix.net
Research analysts at FBR & Co. lifted their FY2019 earnings per share estimates for shares of BioCryst Pharmaceuticals in a note issued to investors on Thursday, according to Zacks .
Tags: post
expected
earnings
pharmaceuticals
Leerink Swann Issues Q4 2016 Earnings Estimate for Regeneron Pharmaceuticals
2015-11-08 00:21:39| Biotech - Topix.net
Leerink Swann issued their Q4 2016 earnings per share estimates for Regeneron Pharmaceuticals in a report issued on Thursday, Zacks reports. Leerink Swann analyst J. Schwartz expects that the brokerage will post earnings of $2.79 per share for the quarter.
Tags: issues
estimate
earnings
pharmaceuticals
Sites : [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] next »